Giagulli VA - Search Results

1

Physiopathology of plasma androstanediol-glucuronide.

Vermeulen A, Giagulli VA. Vermeulen A, et al. Among authors: giagulli va. J Steroid Biochem Mol Biol. 1991 Nov;39(5B):829-33. doi: 10.1016/0960-0760(91)90032-z. J Steroid Biochem Mol Biol. 1991. PMID: 1835405

2

Increased free testosterone but normal 5 alpha-reduced testosterone metabolites in obese premenopausal women.

Giagulli VA, De Pergola G, Giorgino F, Cignarelli M, Abbaticchio G, Vermeulen A, Giorgino R. Giagulli VA, et al. Clin Endocrinol (Oxf). 1992 Jun;36(6):553-8. doi: 10.1111/j.1365-2265.1992.tb02264.x. Clin Endocrinol (Oxf). 1992. PMID: 1424180

3

Increased plasma 5 alpha-androstane-3 alpha,17 beta-diol glucuronide concentration in clinically euthyroid women with suppressed plasma thyrotropin levels: further evidence for generalized tissue overexposure to thyroid hormones in these subjects.

Giagulli VA, Vermeulen A. Giagulli VA, et al. J Clin Endocrinol Metab. 1992 Jun;74(6):1465-7. doi: 10.1210/jcem.74.6.1592894. J Clin Endocrinol Metab. 1992. PMID: 1592894

4

Is plasma 5 alpha-androstane 3 alpha, 17 beta-diol glucuronide a biochemical marker of hirsutism in women?

Giagulli VA, Giorgino R, Vermeulen A. Giagulli VA, et al. J Steroid Biochem Mol Biol. 1991 Jul;39(1):55-61. doi: 10.1016/0960-0760(91)90013-u. J Steroid Biochem Mol Biol. 1991. PMID: 1829956

5

Precursors of plasma androstanediol- and androgen-glucuronides in women.

Giagulli VA, Verdonck L, Giorgino R, Vermeulen A. Giagulli VA, et al. J Steroid Biochem. 1989 Nov;33(5):935-40. doi: 10.1016/0022-4731(89)90243-4. J Steroid Biochem. 1989. PMID: 2532273

6

Hormonal effects of an orally active 4-azasteroid inhibitor of 5 alpha-reductase in humans.

Vermeulen A, Giagulli VA, De Schepper P, Buntinx A, Stoner E. Vermeulen A, et al. Among authors: giagulli va. Prostate. 1989;14(1):45-53. doi: 10.1002/pros.2990140106. Prostate. 1989. PMID: 2538808

7

Pathogenesis of the decreased androgen levels in obese men.

Giagulli VA, Kaufman JM, Vermeulen A. Giagulli VA, et al. J Clin Endocrinol Metab. 1994 Oct;79(4):997-1000. doi: 10.1210/jcem.79.4.7962311. J Clin Endocrinol Metab. 1994. PMID: 7962311

8

Comparison of plasma androgen glucuronide levels after percutaneous or peroral androgen treatment in men: evidence for important splanchnic contribution to plasma 17 beta-hydroxyandrogen glucuronides.

Giagulli VA, Verdonck L, Deslypere JP, Giorgino R, Vermeulen A. Giagulli VA, et al. J Clin Endocrinol Metab. 1993 Feb;76(2):429-31. doi: 10.1210/jcem.76.2.8432786. J Clin Endocrinol Metab. 1993. PMID: 8432786

9

Origin and significance of plasma androsterone glucuronide levels: a parameter of adrenal androgen secretion and hepatic 5 alpha-reductase activity.

Giagulli VA, Giorgino R, Vermeulen A. Giagulli VA, et al. J Clin Endocrinol Metab. 1993 Apr;76(4):918-23. doi: 10.1210/jcem.76.4.8473406. J Clin Endocrinol Metab. 1993. PMID: 8473406

10

Hormonal effects of a 5 alpha-reductase inhibitor (finasteride) on hormonal levels in normal men and in patients with benign prostatic hyperplasia.

Vermeulen A, Giagulli VA, De Schepper P, Buntinx A. Vermeulen A, et al. Among authors: giagulli va. Eur Urol. 1991;20 Suppl 1:82-6. doi: 10.1159/000471752. Eur Urol. 1991. PMID: 1722168 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

136 results

Search Page

Filters